AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Daptomycin

12 registrations across 2 African markets— 11 active

Markets with Daptomycin

🇿🇦South Africa
10 registrations
9 active
🇹🇿Tanzania
2 registrations
2 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
XELODAPTO 500🇿🇦South AfricaPharmaco Distribution (Pty) LtdactiveJul 2029
DAPTOMYCIN EQUITY🇿🇦South AfricaEquity Pharmaceutical (Pty) LtdactiveMar 2028
DAPICUB🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveMar 2028
DABUCOR 500🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveFeb 2028
DABUCOR 350🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveFeb 2028
CUBACT🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveOct 2027
CUSYN🇿🇦South AfricaPharma Dynamics (Pty) LtdactiveOct 2027
CUBICIN🇿🇦South AfricaMSD (Pty) LtdsuspendedMar 2023
RELDAPTOS 500🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
DAPTOMYCIN CIPLA 500🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
GAPOBAK 350
Lyophilized Powder for Injection
🇹🇿TanzaniaHetero Labs Limitedactive—
GAPOBAK 500
Lyophilized Powder for Injection
🇹🇿TanzaniaHetero Labs Limitedactive—

Daptomycin in Africa — Regulatory Overview

Daptomycin is registered across 2 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 11 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.